TD-101

N/A

Report date: 2024/12/05 16:51:55
NME

Base Information

Drug NameTD-101
Drug Alias NamePachyonychia congenita siRNAsdTD-K6a.513a.12TD-K6a.513a.12siRNA sdTD101Reveker +[8] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceKeratins inhibitors
TargetsKeratins
Therapy Area/IndicationsPachyonychia Congenita
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTransdermal Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTransdermal CorpPachyonychia Congenita Consortium
Active IndicationsN/A
Inactive IndicationsPachyonychia Congenita

Other Information

ATC CodeN/A
Related LinksN/A